PRPs Role in Cartilage Preservation and Disease Modification Unlike traditional treatments that primarily suppress symptoms , PRP has shown potential to slow OA progression and enhance cartilage repair : A study using MRI imaging found that patients receiving PRP had higher cartilage thickness and lower cartilage degeneration scores compared to those receiving HA (PMID: 35188121)
TB-500 and Thymosin Beta-4 are also prohibited by WADA/USADA under S2 (Peptide Hormones, Growth Factors, Related Substances and Mimetics), applicable at all times both in-competition and out-of-competition TB-500 / Thymosin Beta-4 Clinical Trials: The RGN-352 and RGN-259 Programs RegeneRx Biopharmaceuticals has pursued two clinical development programs for Thymosin Beta-4, providing the most substantial human clinical data available for any TB-500-related compound: RGN-352 (Injectable Thymosin Beta-4 for Cardiac Repair): Phase 1 trial (completed): A double-blind, placebo-controlled study enrolled 40 healthy volunteers across four cohorts of 10 subjects each, testing escalating dose levels of intravenous Thymosin Beta-4 administered daily over 14 days
Thats why we offer vitamin B12 injections to our clients
When used as part of a structured program, its proposed vascular and regenerative mechanisms may complement physical therapy protocols, though no controlled clinical trials have established additive or synergistic outcomes to date
THIS IS NOT REAL MEDICATION
Anaphylaxis, serious skin reactions (including toxic epidermal necrolysis and Stevens-Johnson syndrome), and other hypersensitivity reactions have been reported with PAXLOVID [see Adverse Reactions (6.1)]
